Search

Your search keyword '"van Blitterswijk M"' showing total 116 results

Search Constraints

Start Over You searched for: Author "van Blitterswijk M" Remove constraint Author: "van Blitterswijk M"
116 results on '"van Blitterswijk M"'

Search Results

1. Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis

2. Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis

4. Unravelling the clinical spectrum and the role of repeat length in C9ORF72 repeat expansions

5. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis

7. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

8. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

9. Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis

10. CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia

11. A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories

12. Scientific correspondence

13. VAPB and C9orf72 mutations in 1 familial amyotrophic lateral sclerosis patient

14. Identical twins with the C9orf72 repeat expansion are discordant for ALS

15. Genetic Overlap between Apparently Sporadic Motor Neuron Diseases

16. Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis

17. C9ORF72 repeat expansions in cases with previously identified pathogenic mutations

18. Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases

21. Expanded ATXN2CAG repeat size in ALS identifies genetic overlap between ALS and SCA2

22. Motor neuron disease in 2012: Novel causal genes and disease modifiers.

23. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

24. Upper motor neuron-predominant motor neuron disease presenting as atypical parkinsonism: A clinicopathological study.

25. Deciphering Distinct Genetic Risk Factors for FTLD-TDP Pathological Subtypes via Whole-Genome Sequencing.

26. Abundant transcriptomic alterations in the human cerebellum of patients with a C9orf72 repeat expansion.

27. PolyGR and polyPR knock-in mice reveal a conserved neuroprotective extracellular matrix signature in C9orf72 ALS/FTD neurons.

29. Clinical testing panels for ALS: global distribution, consistency, and challenges.

30. Analysis of Structural Variants Previously Associated With ALS in Europeans Highlights Genomic Architectural Differences in Africans.

31. Advances in sequencing technologies for amyotrophic lateral sclerosis research.

32. Poly(ADP-ribose) promotes toxicity of C9ORF72 arginine-rich dipeptide repeat proteins.

33. Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations.

34. Revealing the Mutational Spectrum in Southern Africans With Amyotrophic Lateral Sclerosis.

35. Long-read targeted sequencing uncovers clinicopathological associations for C9orf72-linked diseases.

36. Unravelling the clinical spectrum and the role of repeat length in C9ORF72 repeat expansions.

37. C9orf72 -derived arginine-containing dipeptide repeats associate with axonal transport machinery and impede microtubule-based motility.

38. Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia.

39. Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3.

40. Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers.

41. Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases.

42. Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers.

43. Microglia in frontotemporal lobar degeneration with progranulin or C9ORF72 mutations.

44. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD.

45. Long-read sequencing across the C9orf72 'GGGGCC' repeat expansion: implications for clinical use and genetic discovery efforts in human disease.

46. TMEM106B haplotypes have distinct gene expression patterns in aged brain.

47. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.

49. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.

50. Unaffected mosaic C9orf72 case: RNA foci, dipeptide proteins, but upregulated C9orf72 expression.

Catalog

Books, media, physical & digital resources